Godsey & Gibb’s Bristol-Myers Squibb Rights CELG.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-19,000
Closed -$7K – 105
2020
Q4
$7K Hold
19,000
– – ﹤0.01% 101
2020
Q3
$7K Hold
19,000
– – ﹤0.01% 80
2020
Q2
$8K Buy
+19,000
New +$8.6K ﹤0.01% 83

Other funds holding CELG.RT

Godsey & Gibb's CELG.RT Position: Q1 2021 in Review

Godsey & Gibb sold out of Bristol-Myers Squibb Rights (CELG.RT) in Q1 2021, closing a stake of 19,000 shares — an estimated $7K sold.

Godsey & Gibb first reported a position in CELG.RT in Q2 2020 and held it in 3 quarters. The position peaked at $8K in Q2 2020. 20 funds tracked by Wall St. Rank hold CELG.RT as of Q1 2021.

  • Godsey & Gibb reported no remaining Bristol-Myers Squibb Rights position as of Q1 2021 after selling out during the quarter.
  • Godsey & Gibb sold 19,000 Bristol-Myers Squibb Rights shares in Q1 2021, an estimated $7K.
  • Godsey & Gibb first reported a position in Bristol-Myers Squibb Rights in Q2 2020 and held it in 3 quarters.
  • Godsey & Gibb's Bristol-Myers Squibb Rights position peaked at $8K in Q2 2020.
  • 20 funds tracked by Wall St. Rank held Bristol-Myers Squibb Rights as of Q1 2021.

Based on Godsey & Gibb's 13F filing for Q1 2021, filed 13 May 2021.